The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

PHST PJSC PHARMSTANDARD GDR (4 GDRS EACH REPR 1 ORD) (REG S)



Income Statement  ($ m) 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Continuing Operations
Revenue  1459.44 1637.49 1791.67 1118.56 642.29
Operating Profit/(Loss)  378.06 401.12 496.05 377.92 234.07
Net Interest  1.03 1.10 3.98 11.72 6.36
Profit Before Tax  384.50 405.03 498.11 374.99 240.58
Profit After Tax  302.22 321.29 374.33 301.06 189.59
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  302.22 321.29 374.33 301.06 189.59
Attributable to:
Minority Interests  -1.78 -5.58 -3.60 -6.90 -2.47
Equity Holders of Parent Company  300.43 315.71 370.72 294.17 187.12
 
Continuing EPS
Earnings per Share - Basic  828.26¢ 892.18¢ 1070.55¢ 809.14¢ 514.70¢
Earnings per Share - Diluted  828.26¢ 892.18¢ 1070.55¢ 809.14¢ 514.70¢
Earnings per Share - Adjusted  828.26¢ 892.18¢ 1070.55¢ 809.14¢ 514.70¢
Continuing and Discontinued EPS
Earnings per Share - Basic  828.26¢ 892.18¢ 1070.55¢ 809.14¢ 514.70¢
Earnings per Share - Diluted  828.26¢ 892.18¢ 1070.55¢ 809.14¢ 514.70¢
Earnings per Share - Adjusted  828.26¢ 892.18¢ 1070.55¢ 809.14¢ 514.70¢
 
Dividend per Share  0.00¢ 0.00¢ 0.00¢ 0.00¢ 0.00¢

Balance Sheet  ($ m) 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Assets
Non-Current Assets
Property, Plant & Equipment  129.40 199.97 209.50 167.61 147.24
Intangible Assets  209.93 263.46 97.39 53.31 48.37
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 14.31 61.31 129.79 148.58
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  44.41 49.47 53.90 8.20 9.82
  383.73 527.21 422.10 358.92 354.01
Current Assets
Inventories  223.29 276.45 227.68 120.36 138.82
Trade & Other Receivables  480.09 512.45 750.56 339.20 246.57
Cash at Bank & in Hand  168.22 277.22 467.26 145.83 195.82
Current Asset Investments  107.69 146.42 44.20 108.22 189.21
Other Current Assets  0.00 0.18 0.00 0.00 0.00
  979.29 1212.71 1489.70 713.60 770.41
 
Total Assets  1363.02 1739.92 1911.80 1072.52 1124.42
 
Liabilities
Current Liabilities
Borrowings  -22.92 -7.92 -221.37 -75.71 -62.97
Other Current Liabilities  -374.94 -418.79 -788.16 -287.96 -301.66
  -397.86 -426.71 -1009.53 -363.66 -364.63
 
Net Current Assets  581.43 786.01 480.17 349.94 405.78
 
Non-Current Liabilities
Borrowings  0.00 0.00 0.00 0.00 0.00
Provisions  -18.18 -25.64 -13.51 -10.36 -4.29
Other Non-Current Liabilities  -0.29 -2.91 -4.59 -1.58 -1.16
  -18.47 -28.55 -18.09 -11.94 -5.45
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -416.33 -455.26 -1027.62 -375.60 -370.08
 
Net Assets  946.69 1284.66 884.18 696.91 754.34
 
Capital & Reserves
Share Capital  1.18 1.24 1.15 0.65 0.51
Share Premium Account  0.00 0.00 0.00 0.00 0.00
Other Reserves  0.72 -0.17 0.71 12.43 19.98
Retained Earnings  928.69 1229.50 838.35 655.74 709.83
Shareholders Funds  930.59 1230.58 840.21 668.81 730.33
 
Minority Interests/Other Equity  16.09 54.09 43.97 28.10 24.01
Total Equity  946.69 1284.66 884.18 696.91 754.34

Ratios - based on IFRS 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Continuing Operations
PE Ratio - Adjusted  0.02 0.02 0.01 0.01 0.01
PEG - Adjusted  0.00 0.00 0.00 0.00 0.00
Earnings per Share Growth - Adjusted  32.68% 7.72% 19.99% -24.42% -36.39%
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  4023.59¢ 4.63¢ 5173.76¢ 3076.69¢ 1766.67¢
Pre-Tax Profit per Share  1060.06¢ 1.14¢ 1438.39¢ 1031.43¢ 661.74¢
Operating Margin  25.90% 24.50% 27.69% 33.22% 37.23%
Return on Capital Employed  49.56% 38.50% 49.14% 53.00% 31.94%
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  1362.06¢ 2794.88¢ 2043.18¢ 1628.61¢ 1804.44¢
Net Gearing  -15.61% -21.88% -29.27% -10.48% -18.19%

Data is provided by Morningstar


Market

Company Information
Updated Monthly
Company address Likhachevsky Drive, 5 b, Dolgoprudny, Moscow, 141701, Russian Federation
Company website http://www.pharmstd.com
Market cap(in millions)* £ 419.63
Listing/Admission to trading 11 May 2007
Trading service International Order Book
Market Main Market
Listing category Standard GDRs
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
25-Aug-16
FTSE index -
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register US
Segment IOBE
MiFID Status Regulated Market
Exchange market size 5,000
SEDOL B1W4MH7
ISIN number US7171402065



PJSC PHARM S share fundamentals (PHST)